Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 19, 2018
Pharmacy Choice - News - Front Page Healthcare News - August 19, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/19/18 - Delivery, Installation, Commissioning, Personnel Training And Warranty Service Of Medical Equipment And Equipment [TendersInfo (India)]
Contract notice: "delivery, Installation, Commissioning, Personnel training and warranty service of medical equipment and equipment for the needs of" dr. Short description: The designated contractor supplies, installs, installs, tests and puts into operation medical equipment and equipment grouped in 4 distinct positions- endoscopic equipment, diag
8/19/18 - FDA approves Teva's generic of Mylan's EpiPen [Jerusalem Post (Israel)]
The US Food and Drug Administration has approved Teva Pharmaceutical Industries Ltd. s generic version of Mylan NV s life-saving allergy injection, EpiPen, at a time when regulators are looking to lower healthcare costs. There has also been a shortage of EpiPen in North America, Europe and Canada since earlier this year due to manufacturing d
8/19/18 - Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
Health Canada is reviewing the long-term potential health impacts of the NDMA impurity on patients. Although Health Canada believes that the NDMA was introduced as a result of a change in manufacturing processes at Zhejiang Huahai Pharmaceuticals in 2012, some Canadian companies may have been using the affected valsartan active ingredient for less
8/19/18 - Week Ahead In Pharmaceuticals: 7 Stocks To Watch (TNXP, REGN, KALA...)
Barely days after striking down Regeneron Pharmaceuticals Inc.' s request for an updated label for EYLEA, the FDA greenlighted the same on Friday, paving way for a 12- week dosing regimen of the drug for patients with wet age-related macular degeneration. Mylan's EpiPen, the most-widely prescribed epinephrine auto-injector in the U.S., and the one
8/18/18 - Albumin (As Excipient) Market to Reach US$ 1200 Mn by 2019
Albany, NY 08/18/2018 Global Albumin Market Snapshots. The global albumin market was valued at US$ 750 Mn in 2017 and is anticipated to reach US$ 1200 Mn by 2026 at a CAGR of over 5.0% from 2018 to 2026. For instance, in May 2017, China's Food and Drug Administration granted approval to clinical trials of human blood albumin produced from
8/18/18 - Army Seeks Tick-Borne Encephalitis Vaccine Development
The U.S. Army Medical Research Acquisition Activity has issued a sources sought notice for the development of tick-borne encephalitis vaccine for use by U.S. service members. Excerpts of the notice state: The vaccine must be European Medicines Agency approved, and shall achieve U.S. Food and Drug Administration licensure. For more information about
8/18/18 - As Opioid Overdose Deaths Increase, Senator Markey Queries FDA About Inappropriate Fentanyl Prescribing
An analysis of the FDA' s Risk Evaluation and Mitigations Strategies- a series of specific actions required by the FDA of a drug manufacturer that is intended to lessen the risks of the drug being sold- for this specific class of fentanyl medications indicated that 42 percent of these prescriptions may not have been prescribed appropriately.
8/18/18 - BioSig Technologies Closes Private Placement [Kuwait Times]
-BioSig Technologies, Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology marketplace, today announced that the Company has received final proceeds from an oversubscribed capital raise, totaling approximately $6,000,000.
8/18/18 - Birth Control App Highlights Emerging Health Tech Market
London The condom, the pill and now, the smartphone? Apps are incredibly popular and there s nothing inherently wrong about using tech to support our health, said Bekki Burbidge, deputy chief executive of the Family Planning Association, a British sexual health organization. But they re also an area that is fairly unregulated and
8/18/18 - Birth control by smartphone app?
LONDON- The condom, the pill and now, the smartphone? But reports of unwanted pregnancies and investigations by authorities in two countries in Europe, where it received EU certification in 2017, have raised questions about marketing what is essentially a health monitor as a contraceptive. "Apps are incredibly popular and there's nothing inherentl
8/18/18 - Bunion (Hallux Valgus) Treatment Market Have Turned Into a $8 Billion Industry Growing at a CAGR of 6.5% - Forecast 2108-2023: Market Research Future published a study report on Bunion (Hallux Valgus) Treatment Market. This report studies the global
Pune, India 08/18/2018 Market Highlights:. A bunion is an enlargement of bone or tissue around the joint at the base of the big toe. The big toe may turn toward the second toe.
8/18/18 - Cutter Staplers Market Will Hit at a CAGR of 8.8% from 2017 to 2025
Albany, NY 08/17/2018 Transparency Market Research observes that competition in the global cutter staplers market is quite cut throat. Some of the leading companies in the global market are Johnson& Johnson Services, Inc., Purple Surgical International Ltd., Medtronic Plc., Victor Medical Instruments Co., Ltd., and Frankenman International Lt
8/18/18 - Drug Delivery Systems Market Projected to Reach US$ 900 Bn by 2019
Albany, NY 08/18/2018 Drug Delivery Systems Market: Snapshot. The global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. For instance, on September 2017, Baxter International Inc. announced the launch of De
8/18/18 - Faso Highlights FDA Approval of Generic EpiPen Auto-Injector
Rep. Faso had written to FDA Commissioner Dr. At the time, the FDA had just added epinephrine auto-injectors to the FDA' s list of existing drug shortages. I'm glad to see the FDA approve additional effective and safe devices that will lower costs for consumers and expand access. "
8/18/18 - FDA approves first generic competitor to EpiPen [T-break Tech (Middle East)]
It was approved after the FDA issued new guidance for generic copies of products like the EpiPen, which combines a drug with a specialized device to deliver it fast when people have life-threatening allergic reactions. This approval means patients living with severe allergies who require constant access to lifesaving epinephrine should have a lower
8/18/18 - FDA Clears SPR Therapeutics Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management [Tehran Times (Iran)]
SPR Therapeutics, Inc., a leader in neurostimulation technology for pain, today announced that the U.S. Food and Drug Administration has cleared its SPRINTendura and extensa Peripheral Nerve Stimulation Systems. With the ease of use and dual lead capabilities weve built into the SPRINT System we look forward to advancing the early use of neurostimu
8/18/18 - FDA gives green light to study of cholangiocarcinoma drug [Tehran Times (Iran)]
Sirnaomics, Inc., a biopharmaceutical company in discovery and development of RNAi therapeutics, announces that the U.S. Food and Drug Administration has approved the companys first oncology IND application. Although it is more common in Asia, its incidence in Europe and North America has increased significantly in recent decades. In 2017, STP705 w
8/18/18 - FDA warned Froedtert doctor of problems with brain device research. State board did not act. [Syrian Arab News Agency]
While doing research on a brain device in 2015, Marc Lazzaro got a visit from an investigator with U.S. Food and Drug Administration. Lazzaro, a doctor with Froedtert Hospital in Wauwatosa, was testing onedevice that is implanted in the brain to treat aneurysms and another one used to remove clots. The Wisconsin Department of Safety and Professiona
8/18/18 - FSD Pharma and SciCann Therapeutics Launch Clinical Research Program in Israel [T-break Tech (Middle East)]
FSD Pharma Inc. has announced the launch of a clinical research collaborative program in Israel, via its strategic R&D partner, SciCann Therapeutics Inc.. As announced previously, FSD Pharma has secured the exclusive licensing rights for the manufacturing and distribution of SciCann`s line of proprietary, patent-pending, cannabinoid-based and...
8/18/18 - Global 3D Printed Medical Devices Market Is Predicted to Surge at an Outstanding CAGR of 18.1% over the Forecast Period of 2017-2027: ResearchMoz presents professional and in-depth study of "3D Printed Medical Devices Market: Global Industry Analysis
Albany, NY 08/17/2018 3 D printed medical devices are novel medical devices that involve process of developing three dimensional solid objects from a digital model. Patient specific treatment is the main advantage of 3 D printing technology in the healthcare industry. In the healthcare industry, 3 D printing technology is used to develop medi
8/18/18 - Global Clinical Laboratory Test Market Expected to Reach 344500 Million US$ by the End of 2025: The growing geriatric population base, primarily in the European and North American countries, is also anticipated to provide huge growth opportunities in
Pune, Maharashtra 08/17/2018 Global Clinical Laboratory Test Market: Summary. The increase in aging population and amplified acute and long-term healthcare needs are driving the growth of clinical laboratory tests market at a global level. For example, approximately more than 30% of the laboratories in North America, Europe, and Japan have im
8/18/18 - Global Refractive Surgical Devices Market Report 2018 Industry Growth, Trends, Size, Forecast to 2025
The Report describe Refractive Surgical Devices Introduction, product scope, market overview, opportunities, risk, driving force also to analyze the top manufacturers, with sales, revenue, and price, market type and application, with sales market sha...
8/18/18 - Himes, Murphy defend Affordable Care Act amid challenges from Trump administration [The Hour, Norwalk, Conn.]
"The president, every week, seems to come up with new and creative ways to try to destabilize the existing healthcare system," said U.S. Sen. Murphy, a member of the U.S. Senate Health, Education, Labor and Pensions Committee, U.S. Rep. Jim Himes, D- Conn., and state Senate Majority Leader Bob Duff, D- Norwalk, led the discussion with about two doz
8/18/18 - In Adam Putnam's Hometown, Democrats Offer Solutions on Health Care Issues
In Polk County Friday, Democratic candidates and health care experts held a round table to discuss the issues caused by Republican efforts to dismantle the Affordable Care Act, and the decision not to expand Medicaid. Candidates who participated included: Kristen Carlson, CD-15; Andrew Learned, CD-15; Bill Pollard, CD-17; Catherine Price, Senate Di
8/18/18 - KALYDECO approved as first CF drug in children under 24 months [Syrian Arab News Agency]
Vertex Pharmaceuticals Incorporated has announced the U.S. Food and Drug Administration approved KALYDECO to include use in children with cystic fibrosis ages 12 to.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415